Abstract 1766: SGN-ALPV a novel, investigational vedotin ADC demonstrates highly effective targeting of oncofetal phosphatases ALPP and ALPPL2 in preclinical models

胎盘碱性磷酸酶 癌症研究 碱性磷酸酶 人源化抗体 单克隆抗体 化学 医学 抗体 生物化学 免疫学
作者
Sarah Anderson,Nanna Hansen,Robert Lawrence,Aroon T. Chande,David Ortiz,Christopher M. Carosino,Esther S. Trueblood,Nicole M. Stevens,Kerry Klussman,Angela Epp,Bill Arthur,Shyra J. Gardai,Hector Rincon
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:82 (12_Supplement): 1766-1766 被引量:1
标识
DOI:10.1158/1538-7445.am2022-1766
摘要

Abstract Antibody-drug conjugates (ADC) leverage the specificity of antibodies to direct the delivery of potent cytotoxic agents to cancer cells. To fully leverage this specificity, targets with significant differential tumor versus normal tissue expression are ideal for ADC development. Placental alkaline phosphatases, ALPP and ALPPL2, are proteins present during fetal development but are found in several tumor types, making them an attractive ADC target. These cell membrane-attached phosphatases form homo- and heterodimers and play key roles in nucleotide recycling. SGN-ALPV is a novel investigational vedotin ADC comprised of a humanized IgG1 monoclonal antibody conjugated to the microtubule disrupting agent monomethyl auristatin E (MMAE) via a protease-cleavable peptide linker that has been clinically validated in multiple ADC programs. Here we characterize the target antigens, ALPP and ALPPL2, and evaluate SGN-ALPV antitumor activity in preclinical models. Immunohistochemistry and genomic data mining showed that ALPP and ALPPL2 have a highly restricted normal tissue expression yet high expression in several solid tumor types including ovarian, endometrial, germ cell, non-small cell lung and gastric carcinomas. Importantly, normal tissue expression is restricted to placenta and reproductive tissue, with low levels in lung tissue. SGN-ALPV utilizes a humanized antibody, h12F3, that is highly specific for both human and cynomolgus monkey ALPP and ALPPL2 proteins, but not other related phosphatases. In vitro, upon binding to SGN APLV, the antigens, ALPP and ALPPL2, are internalized to lysosomal vesicles releasing the MMAE payload, whose cytotoxic features drive mitotic arrest, apoptosis, and the induction of immunogenic cell death. Additionally, SGN-ALPV mediates antibody dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) in vitro but lacks complement-dependent cytotoxicity. In preclinical studies, SGN-ALPV exhibits robust antitumor activity in cell line- and patient-derived xenograft models of ovarian, lung, pancreatic, and gastric carcinoma including models with both homogenous and heterogeneous expression of ALPP and ALPPL2, consistent with robust bystander activity of vedotin ADCs. Although, the contribution of ADCC and ADCP in vivo is currently unknown, it is expected that the antitumor activity of SGN-ALPV is mediated by MMAE cytotoxicity. SGN-ALPV was well tolerated in non-human primates (NHP) and exhibited linear pharmacokinetic characteristics, with a toxicity profile consistent with other vedotin-based ADCs. In summary, differential expression of ALPP and ALPPL2 in the tumor versus normal tissue, antibody specificity, antitumor activity, and tolerability of SGN-ALPV provide a strong rationale for the initiation of a planned first-in-human Phase 1 clinical study. Citation Format: Sarah Anderson, Nanna Hansen, Robert Lawrence, Aroon T. Chande, David Ortiz, Christopher Carosino, Esther Trueblood, Nicole Stevens, Kerry Klussman, Angela Epp, Bill Arthur, Shyra Gardai, Hector Rincon. SGN-ALPV a novel, investigational vedotin ADC demonstrates highly effective targeting of oncofetal phosphatases ALPP and ALPPL2 in preclinical models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1766.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
eny完成签到 ,获得积分10
1秒前
冰激凌发布了新的文献求助10
1秒前
山猪尝细糠完成签到,获得积分10
2秒前
成就映秋发布了新的文献求助10
3秒前
3秒前
义气的一德完成签到,获得积分10
8秒前
Mxue完成签到,获得积分10
8秒前
8秒前
苦我心志完成签到 ,获得积分10
8秒前
机灵芷文发布了新的文献求助10
8秒前
9秒前
简洁应助LCXLA采纳,获得20
9秒前
11秒前
科研通AI2S应助山暮而归采纳,获得10
12秒前
12秒前
12秒前
成就映秋完成签到,获得积分10
12秒前
Astronaut_cat完成签到,获得积分10
13秒前
小熊发布了新的文献求助30
14秒前
yx_cheng发布了新的文献求助10
15秒前
Iris完成签到,获得积分10
15秒前
eny关注了科研通微信公众号
15秒前
xiongyh10发布了新的文献求助10
16秒前
16秒前
缄默完成签到,获得积分10
16秒前
yang发布了新的文献求助10
17秒前
21秒前
21秒前
kiki发布了新的文献求助30
23秒前
24秒前
24秒前
小二郎应助苹果蜗牛采纳,获得10
25秒前
微笑的冰烟完成签到,获得积分10
25秒前
日富一日的fighter完成签到,获得积分10
25秒前
科研通AI2S应助中央采纳,获得10
25秒前
27秒前
27秒前
28秒前
可爱的函函应助yang采纳,获得10
28秒前
29秒前
高分求助中
Sustainability in Tides Chemistry 2000
Bayesian Models of Cognition:Reverse Engineering the Mind 800
Essentials of thematic analysis 700
A Dissection Guide & Atlas to the Rabbit 600
Very-high-order BVD Schemes Using β-variable THINC Method 568
Внешняя политика КНР: о сущности внешнеполитического курса современного китайского руководства 500
Revolution und Konterrevolution in China [by A. Losowsky] 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3124648
求助须知:如何正确求助?哪些是违规求助? 2774953
关于积分的说明 7724821
捐赠科研通 2430484
什么是DOI,文献DOI怎么找? 1291144
科研通“疑难数据库(出版商)”最低求助积分说明 622066
版权声明 600323